OraSure Gears For OTC HIV Test Trials, Faces Cryosurgery Distributor Shortfall
This article was originally published in The Gray Sheet
Executive SummaryOraSure Technologies is preparing to launch a series of studies in September to support potential over-the-counter use of its OraQuick Advance rapid HIV test
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.